About the Study

Congenital Diaphragmatic Hernia (CDH): A study in infants to evaluate the effectiveness of milrinone vs. placebo in improving heart and lung function and outcomes

This research study is being done to find out whether a drug called milrinone, when given to infants with congenital diaphragmatic hernia (CDH), will help the heart work better by supplying oxygen to the lungs and tissues. The main purpose of this initial pilot study is to understand better how milrinone works to help the heart and lungs give oxygen to the tissues and other organs in infants with CDH. We are hoping this pilot study will support and look at the possibility and safety of conducting a much larger study. The following things are part of this study: the study drug (milrinone), or placebo (sugar solution), head ultrasounds, maternal and baby medical chart review, and follow up questionnaires.

Interested in learning more?

Full Study Name: Milrinone in Congenital Diaphragmatic Hernia